标题: CURRENT ISSUES IN UROLOGY

地点: Moscow, 俄罗斯

开始日期: 2012-11-12

结束日期: 2012-11-14

场地:

参与者的参与条件:

注册套餐 includes transportation ( fromto airport, fromto conference venue), simultaneous translation from Russian to English language , 参与证书 (英语) ,participation in scientific sessions, 会议资料, visit to the exhibition and 10-30% discount for accomodation in hotel.

 

NB科学

(最后期限 – 二月 30, 2012)

 

TOPICS

 

Drugs for treatment of kidney cancer

Evaluating the effectiveness of treatment for kidney cancer. Side effects of therapy.

Criteria for evaluating the effectiveness of the drug: RECIST? Choi?

Common side effects of therapy for kidney cancer. The effects of targeted therapies on the cardiovascular system

Targeted drugs and haemostasis

Nesvetlokletochnogo treatment for kidney cancer

Alternative modes and drug regimens for renal cell carcinoma

Treatment of elderly patients

 

The situation in Russia

A new classification of renal cell carcinoma TNM

Diagnosis of renal cancer

Surgical treatment of kidney cancer

Prognostic model for kidney cancer

Adjuvant therapy for kidney cancer

Discussion: The surgical and adjuvant treatment

Metastases of renal cancer in the bone

Surgical treatment of metastatic renal cell carcinoma

New in the medicinal treatment of metastatic renal cell carcinoma

VHL syndrome and renal cell carcinoma

The stability problem for kidney cancer targeted therapy

Cytoreductive nephrectomy value at the present stage

Drug treatment of metastatic renal cell carcinoma

Resistance to targeted therapy

Locally advanced RCC

Papillary renal cell carcinoma

New agents on the horizon

Small kidney tumor

 

Ablation

Treatment of particular groups of patients with metastatic RCC


Accomodation:

Stay in the heart of the Moscow at a hotel specially discounted for attendees ( 点击这里 ).

for group discounts please contact us by email: 会议@nbscience.com



航班:

tickets ukraine

From Europe to Russia from 50 欧元 ( one way) : http://wizzair.com/?language=EN

问题

Contact NBScience’s

教育/会议部:

Tel: +3.8044.233.2770

会议@nbscience.com

药理

 

 

分类: 干细胞疗法

国家统计局科学

合同研究组织

干细胞疗法